NCT02483533View on ClinicalTrials.gov

Extension Study to Evaluate the Post-Treatment Safety and Duration of Clinical Effect of LIPO-202

PHASE3TerminatedINTERVENTIONAL

Enrollment

100

Participants

Timeline

Start Date

June 30, 2015

Primary Completion Date

December 23, 2015

Study Completion Date

February 26, 2016

Conditions

Central Abdominal Bulging

Interventions

DRUG

LIPO-202

DRUG

Placebo

Sponsors

Collaborators (1)

Neothetics, Inc

All Listed Sponsors

collaborator

Neothetics, Inc

INDUSTRY

lead

Evofem Inc.

INDUSTRY